Why is Caplin Point Laboratories Ltd ?
1
High Management Efficiency with a high ROE of 19.09%
2
Company has a low Debt to Equity ratio (avg) at 0 times
3
The company has declared Positive results for the last 17 consecutive quarters
- NET SALES(Q) Highest at Rs 629.84 cr
- PBDIT(Q) Highest at Rs 223.22 cr.
- PAT(Q) Highest at Rs 178.10 cr.
4
Stock is technically in a Mildly Bullish range
- The technical trend has improved from Sideways on 26-Oct-26 and has generated -10.68% returns since then
- Multiple factors for the stock are Bullish like MACD, KST and OBV
5
With ROE of 17.7, it has a Very Expensive valuation with a 4 Price to Book Value
- The stock is trading at a fair value compared to its peers' average historical valuations
- Over the past year, while the stock has generated a return of 5.77%, its profits have risen by 17% ; the PEG ratio of the company is 1.3
6
Majority shareholders : Promoters
How much should you hold?
- Overall Portfolio exposure to Caplin Point Lab should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Caplin Point Lab for you?
High Risk, Medium Return
Absolute
Risk Adjusted
Volatility
Caplin Point Lab
5.77%
0.16
37.06%
Sensex
-2.0%
-0.13
14.98%
Quality key factors
Factor
Value
Sales Growth (5y)
15.55%
EBIT Growth (5y)
18.45%
EBIT to Interest (avg)
100.00
Debt to EBITDA (avg)
Net Debt is too low
Net Debt to Equity (avg)
-0.24
Sales to Capital Employed (avg)
0.72
Tax Ratio
20.01%
Dividend Payout Ratio
8.50%
Pledged Shares
0
Institutional Holding
7.93%
ROCE (avg)
31.03%
ROE (avg)
19.09%
Valuation Key Factors 
Factor
Value
P/E Ratio
22
Industry P/E
40
Price to Book Value
3.95
EV to EBIT
19.37
EV to EBITDA
17.43
EV to Capital Employed
4.89
EV to Sales
6.08
PEG Ratio
1.31
Dividend Yield
0.39%
ROCE (Latest)
25.26%
ROE (Latest)
17.66%
Loading Valuation Snapshot...
Technical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Bullish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
Mildly Bearish
Bullish
Technical Movement
9What is working for the Company
NET SALES(Q)
Highest at Rs 629.84 cr
PBDIT(Q)
Highest at Rs 223.22 cr.
PAT(Q)
Highest at Rs 178.10 cr.
OPERATING PROFIT TO NET SALES(Q)
Highest at 35.44%
PBT LESS OI(Q)
Highest at Rs 199.54 cr.
EPS(Q)
Highest at Rs 23.43
-1What is not working for the Company
NO KEY NEGATIVE TRIGGERS
Loading Valuation Snapshot...
Here's what is working for Caplin Point Lab
Net Sales - Quarterly
Highest at Rs 629.84 cr and Grown
each quarter in the last five quartersMOJO Watch
Near term sales trend is very positive
Net Sales (Rs Cr)
Operating Profit (PBDIT) - Quarterly
Highest at Rs 223.22 cr. and Grown
each quarter in the last five quartersMOJO Watch
Near term Operating Profit trend is quite positive
Operating Profit (Rs Cr)
Profit After Tax (PAT) - Quarterly
Highest at Rs 178.10 cr. and Grown
each quarter in the last five quartersMOJO Watch
Near term PAT trend is very positive
PAT (Rs Cr)
Operating Profit Margin - Quarterly
Highest at 35.44%
in the last five quartersMOJO Watch
Company's efficiency has improved
Operating Profit to Sales
Profit Before Tax less Other Income (PBT) - Quarterly
Highest at Rs 199.54 cr.
in the last five quartersMOJO Watch
Near term PBT trend is positive
PBT less Other Income (Rs Cr)
Earnings per Share (EPS) - Quarterly
Highest at Rs 23.43
in the last five quartersMOJO Watch
Increasing profitability; company has created higher earnings for shareholders
EPS (Rs)